BriaCell Therapeutics Corp. (BCTX) Form 424B5 — Jun 2, 2026
BriaCell Therapeutics Corp. (BCTX) is offering 1,449,300 common shares at $3.25 per share, raising approximately $4.7 million in gross proceeds. The offering price represents a 10.7% discount to the last reported market price of $3.64 on May 29, 2026, signaling immediate downward pressure on the stock. New investors will face immediate dilution of $0.66 per share, as the offering price is below the company's pro forma net tangible book value of $3.91 per share.
Key figures
- Net Proceeds
- 3940000
- Total Assets
- 33594454
- Cash Position
- 29903628
- Gross Proceeds
- 4710225
- Offering Price
- 3.25
- Shares Offered
- 1449300
- Dilution Per Share
- 0.66
- Public Float Value
- 33500000
- Last Reported Price
- 3.64
- Placement Agent Fee Percent
- 7.5
- Shares Outstanding Post Offering
- 8699787
Price after filing
1 day: +1.2%7 days: -6.1%30 days: +6.1%
Close on the filing date to close N calendar days later (from $3.27). Historical, not a forecast.
AI analysis
Red flags7 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.